We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+0.66%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.83B
AUM Growth
+$1B
Cap. Flow
+$1.04B
Cap. Flow %
13.23%
Top 10 Hldgs %
18.07%
Holding
1,199
New
91
Increased
872
Reduced
184
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 21.33%
2 Financials 13.75%
3 Healthcare 12.59%
4 Consumer Discretionary 10.27%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
976
Pultegroup
PHM
$25.3B
$297K ﹤0.01%
2,699
-3
-0.1% -$341
DRS icon
977
Leonardo DRS
DRS
$12B
$296K ﹤0.01%
+11,590
New +$265K
KMB icon
978
Kimberly-Clark
KMB
$36.5B
$293K ﹤0.01%
2,123
-1,841
-46% -$246K
PCH
979
DELISTED
PotlatchDeltic
PCH
$292K ﹤0.01%
7,414
+2,799
+61% +$119K
BAC.PRL icon
980
Bank of America Series L
BAC.PRL
$3.99B
$292K ﹤0.01%
244
+71
+41% +$83.6K
WH icon
981
Wyndham Hotels & Resorts
WH
$5.48B
$290K ﹤0.01%
+3,922
New +$283K
SPHD icon
982
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.4B
$290K ﹤0.01%
6,526
-578
-8% -$25.5K
SLB icon
983
SLB Ltd
SLB
$75B
$289K ﹤0.01%
6,133
+2,063
+51% +$99.6K
FCN icon
984
FTI Consulting
FCN
$4.18B
$288K ﹤0.01%
1,335
+209
+19% +$44.7K
RVLV icon
985
Revolve Group
RVLV
$1.73B
$288K ﹤0.01%
18,072
-1,490
-8% -$28.5K
ACLS icon
986
Axcelis
ACLS
$4.33B
$287K ﹤0.01%
+2,015
New +$232K
NI icon
987
NiSource
NI
$20.4B
$286K ﹤0.01%
+9,932
New +$280K
AMX icon
988
America Movil
AMX
$71.2B
$284K ﹤0.01%
16,707
+1,025
+7% +$18.9K
CX icon
989
Cemex
CX
$16.3B
$283K ﹤0.01%
44,305
+13,766
+45% +$105K
ARES icon
990
Ares Management
ARES
$30.9B
$283K ﹤0.01%
2,123
-1,916
-47% -$262K
SDG icon
991
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
$281K ﹤0.01%
3,737
+672
+22% +$52.3K
NARI
992
DELISTED
Inari Medical, Inc. Common Stock
NARI
$280K ﹤0.01%
5,808
-12
-0.2% -$532
SFM icon
993
Sprouts Farmers Market
SFM
$8.01B
$278K ﹤0.01%
+3,327
New +$242K
PCVX icon
994
Vaxcyte
PCVX
$8.64B
$277K ﹤0.01%
+3,667
New +$250K
IMCR icon
995
Immunocore
IMCR
$1.73B
$277K ﹤0.01%
8,163
+43
+0.5% +$2.19K
CNXC icon
996
Concentrix
CNXC
$1.57B
$277K ﹤0.01%
4,370
+764
+21% +$45.8K
IONS icon
997
Ionis Pharmaceuticals
IONS
$9.4B
$275K ﹤0.01%
5,777
-4,049
-41% -$166K
JBTM
998
JBT Marel
JBTM
$6.39B
$275K ﹤0.01%
2,894
-1,419
-33% -$134K
SCHX icon
999
Schwab US Large- Cap ETF
SCHX
$74.6B
$273K ﹤0.01%
12,744
EVR icon
1000
Evercore
EVR
$11.8B
$272K ﹤0.01%
+1,306
New +$254K

Similar funds

Oppenheimer Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Oppenheimer Asset Management held 1,199 positions worth $7.83B, up 15% from $6.83B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer Asset Management deployed $1.04B of net new capital in Q2 2024, opening 91 new positions and adding to 872 existing holdings. Its largest new stake was iShares S&P Small-Cap 600 Growth ETF: 199,301 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $20.9M trimmed.

  • Oppenheimer Asset Management's largest Q2 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 199,301 shares worth $25.6M.
  • Oppenheimer Asset Management added most to Microsoft in Q2 2024, an estimated $37.8M increase.
  • Oppenheimer Asset Management's biggest Q2 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $20.9M.
  • Oppenheimer Asset Management fully exited Oshkosh in Q2 2024, selling an estimated $5.61M.
  • Oppenheimer Asset Management's ten largest holdings make up 18% of its $7.83B portfolio in Q2 2024.
  • Oppenheimer Asset Management opened 91 new positions and closed 50 in Q2 2024.
  • Oppenheimer Asset Management's portfolio value rose 15% quarter-over-quarter to $7.83B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.